Who invested in Alchemab Therapeutics?
Alchemab Therapeutics, a HealthTech startup from United Kingdom, raised €29.3 million in a Series A round announced on 9 July 2026. Investors: British Business Bank (lead), SV Health Investors, Dementia Discovery Fund, RA Capital, Eli Lilly, Lightstone Ventures, Ono Venture Investment, Inc, Camford Partners and DCVC.
Alchemab Therapeutics
€29.3 millionSeries AHealthTechBritish Business BankleadSV Health InvestorsDementia Discovery FundRA CapitalEli LillyLightstone VenturesOno Venture Investment, IncCamford PartnersDCVC
United Kingdomeu-startups.com
Questions founders ask
- Who invested in Alchemab Therapeutics?
- British Business Bank, SV Health Investors, Dementia Discovery Fund, RA Capital, Eli Lilly, Lightstone Ventures, Ono Venture Investment, Inc, Camford Partners and DCVC invested in Alchemab Therapeutics's Series A round, announced on 9 July 2026 (source: eu-startups.com).
- Who led Alchemab Therapeutics's Series A round?
- British Business Bank, according to eu-startups.com.
- How much did Alchemab Therapeutics raise?
- €29.3 million in its Series A round, as reported by eu-startups.com.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.